Becton, Dickinson and Company - Corporate Home
  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Clinical Microbiology
      • Diagnostic Accuracy and Efficiency
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
    • Pharmacy
      • BD Hypodermic Needle and Syringe Solutions
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Plastic and Reconstructive Surgery Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
    • Customer Portals
      • Medication Management Customer Login
      • Customer Care Portal Guides and FAQ’s
      • My BD Learning
  • About BD
    • Our Company
      • About BD
      • Segments
      • Leadership
      • Board of Directors
      • Ethics and Compliance
    • BD IV Fluid Support
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • Corporate Sustainability
      • Climate Change
      • Healthy Workforce & Communities
      • Product Impact
      • Supply Chain
      • Transparency
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
      • Supplier Recognition
  • Careers
  • Country

    United States

    • North America
      • Canada (EN)
      • Canada (FR)
      • Mexico
      • United States
      South America
      • América Latina
      • Argentina
      • Chile
      • Colombia
      Europe
      • Belgique
      • België
      • Česká republika
      • Deutschland
      • España
      • Europe
      • France
      • ישראל
      • Italia
      • Nederland
      • Nordics
      • Österreich
      • Polska
      • Schweiz
      • United Kingdom
      Middle East, North Africa, Turkey
      • Middle East, North Africa, Turkey
      • South Africa
      Asia Pacific
      • Australia & New Zealand
      • 中国
      • Greater Asia
      • India
      • 日本
      • 대한민국
      • Southeast Asia
  • Login Here

    Login

  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Clinical Microbiology
      • Diagnostic Accuracy and Efficiency
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
    • Pharmacy
      • BD Hypodermic Needle and Syringe Solutions
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Plastic and Reconstructive Surgery Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
    • Customer Portals
      • Medication Management Customer Login
      • Customer Care Portal Guides and FAQ’s
      • My BD Learning
  • About BD
    • Our Company
      • About BD
      • Segments
      • Leadership
      • Board of Directors
      • Ethics and Compliance
    • BD IV Fluid Support
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • Corporate Sustainability
      • Climate Change
      • Healthy Workforce & Communities
      • Product Impact
      • Supply Chain
      • Transparency
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
      • Supplier Recognition
  • Careers
  • Country

    United States

    • North America
      • Canada (EN)
      • Canada (FR)
      • Mexico
      • United States
    • South America
      • América Latina
      • Argentina
      • Chile
      • Colombia
    • Europe
      • Belgique
      • België
      • Česká republika
      • Deutschland
      • España
      • Europe
      • France
      • ישראל
      • Italia
      • Nederland
      • Nordics
      • Österreich
      • Polska
      • Schweiz
      • United Kingdom
    • Middle East, North Africa, Turkey
      • Middle East, North Africa, Turkey
      • South Africa
    • Asia Pacific
      • Australia & New Zealand
      • 中国
      • Greater Asia
      • India
      • 日本
      • 대한민국
      • Southeast Asia
  • Login here Login

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • BD Innovates
    • Email Alerts
  • Company Info
    • Overview
    • Executive Leadership
    • Annual Reports and Proxy
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Credit Rating
    • Additional Financial Information
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
    • Stock Split History
    • Dividends
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Sustainability
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
    • Contact the Board
    • Reporting Accounting, Internal Accounting Controls or Auditing Matters
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • BD Innovates
  • Email Alerts
Jan 14, 2009 5:49 pm EST
BD Announces Webcast of Annual Meeting of Shareholders
Jan 14, 2009 1:12 pm EST
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
Dec 24, 2008 12:31 pm EST
BD to Present at Investor Healthcare Conferences
Nov 25, 2008 8:27 am EST
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
Nov 5, 2008 6:25 am EST
BD Announces Executive Appointments of President and Chief Financial Officer
Nov 5, 2008 6:15 am EST
BD Announces Results for Fourth Fiscal Quarter and Full Year
Nov 3, 2008 6:25 pm EST
BD to Present at Investor Healthcare Conferences
Oct 2, 2008 5:32 pm EDT
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
Sep 25, 2008 12:15 pm EDT
Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital
Aug 27, 2008 4:26 pm EDT
BD to Present at Investor Healthcare Conferences
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • …
  • Page 89
  • Next Pagearrow_forward
rss_feed News RSS
By reading this content you are acknowledging our forward looking statement.

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company's control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.

  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • accessibilityAccessibility Statement
  • Follow us
    • Linked In
    • Facebook
    • Instagram
    • Twitter
    • Youtube
Quick Links
  • Recalls and Field Actions
  • Careers
  • Cybersecurity
  • Electronic Instructions for Use
  • Events
  • Investors
  • Inclusion, Diversity, Equity & Engagement
  • Literature
  • Live Chat Support
  • News, Media and Blogs
  • Our Company
  • Ethics and Compliance
  • Support
  • Training
Becton, Dickinson and Company

©2025 BD. All rights reserved. BD and the BD Logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners.

  • Contact us
  • Cookie Preferences
  • Privacy Statement
  • Terms of Use
  • Website Accessibility
  • Your Privacy Rights
  • Limit the use of Sensitive Personal Information